Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2019 | Story Igno van Niekerk | Photo Igno van Niekerk
Allon Raiz
Entrepreneurship is the future: Allon Raiz provides tools for tomorrow at recent UFS Business School guest lecture.

Allon Raiz treated staff and students to an entertaining, insightful and thought-provoking session on Lose the business plan: what they don’t teach you about being an entrepreneur on Thursday 10 April 2019 at the Bloemfontein Campus. The University of the Free State (UFS) Business School hosted Raiz for a guest lecture on going beyond the business plan.

Raiz, the founder and CEO of Raizcorp is the host of The Big Small Business Show on Business Day TV. He is also the author of two best-selling entrepreneurial books, and he literally gets down to earth about talking business issues when he takes off his shoes as he takes the stage to deliver a talk.

What they don’t teach you

Raiz started the session by sharing the fact that 96% of small businesses fail within 10 years. From his research and experience, he shared the three main attributes always found when studying successful entrepreneurs: “They see opportunities, take risks and add value.”

He was however clear on the fact that there is no such thing as a typical entrepreneur. “It is not about a set of characteristics, it is about a set of probabilities.”

Effective entrepreneurship education

After sharing his personal journey to entrepreneurial success, Raiz explained that entrepreneurs had different expectations in terms of how much they wanted to earn, and how big they wanted to grow their businesses. Although entrepreneurs come in all shapes and sizes, there are some generic tools which all entrepreneurs can use. These include finding role models, being resilient, and having an internal locus of control. 

The essence of Raiz’s message was that no matter what you want to do, don’t wait and make plans – take action. In short, lose the business plan – start working on the business.

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept